Old Articles: <Older 8861-8870 Newer> |
|
Chemistry World July 16, 2012 Andrew Turley |
Drug spending to hit $1.2tn in 2016 Global expenditure on medicines will top $1.2 trillion in 2016, up from $960 billion in 2011, according to a report from the IMS Institute for Healthcare Informatics. |
Commercial Investment Real Estate Jul/Aug 2012 Mark Vitner |
Market Momentum Modest economic growth keeps commercial real estate on the road to recovery. |
Commercial Investment Real Estate Jul/Aug 2012 Sara Drummond |
Climate Change Adjust your business strategies to succeed in the shifting economic market conditions. |
Commercial Investment Real Estate Jul/Aug 2012 Rich Rosfelder |
At the Office Crossroads While year-over-year increases in secondary market office sales averaged 25 percent in 4Q11 and 1Q12, tertiary markets showed negative growth overall. Are office investors poised to enter these markets or are they biding their time? |
Commercial Investment Real Estate Jul/Aug 2012 Kevin J. Thorpe |
No Replay This year's recovery is not a repeat performance. |
Commercial Investment Real Estate Jul/Aug 2012 Mark Vitner |
Economic Outlook: Uncertainty vs. Modest Gains Though Europe's financial crisis continues to impact the overall economy, the U.S. is less dependent on exports than other developed economies and appears to riding out the global economic storm relatively well. |
Commercial Investment Real Estate Jul/Aug 2012 Leil Koch |
What Happens in Vegas... What happens at the CCIM Live! fall conference won't stay in Vegas: You'll have an inside look at the "new normal" for underwriting deals in the current market, an exclusive view of where the economy -- and commercial real estate -- is headed in 2013. |
Commercial Investment Real Estate Jul/Aug 2012 |
Market Trends High-tech job growth is fueling office absorption in more markets than expected, according to Jones Lang LaSalle. Access to talent is the No. 1 location driver, along with creative space requirements |
Commercial Investment Real Estate Jul/Aug 2012 |
Regional Outlook Aldi expands to Houston... Miami's big deal... Las Vegas retail holds steady... |
Pharmaceutical Executive July 1, 2012 Ben Comer |
John Lechleiter on PhRMA and Innovation Eli Lilly CEO John Lechleiter on his agenda as incoming chairman of PhRMA, US healthcare reform, the euro crisis, and the small problem, of innovation. |
<Older 8861-8870 Newer> Return to current articles. |